SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042885
Filing Date
2021-08-10
Accepted
2021-08-10 07:31:11
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-10q_20210630.htm   iXBRL 10-Q 1715675
2 EX-31.1 grtx-ex311_8.htm EX-31.1 20317
3 EX-31.2 grtx-ex312_9.htm EX-31.2 21350
4 EX-32.1 grtx-ex321_7.htm EX-32.1 8466
5 EX-32.2 grtx-ex322_6.htm EX-32.2 7418
  Complete submission text file 0001564590-21-042885.txt   5767917

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grtx-20210630.xsd EX-101.SCH 39115
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grtx-20210630_cal.xml EX-101.CAL 38113
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grtx-20210630_def.xml EX-101.DEF 87972
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtx-20210630_lab.xml EX-101.LAB 306469
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtx-20210630_pre.xml EX-101.PRE 214143
11 EXTRACTED XBRL INSTANCE DOCUMENT grtx-10q_20210630_htm.xml XML 1030533
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 211158432
SIC: 2834 Pharmaceutical Preparations